Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
The article "Risk prediction tools in cardiovascular disease prevention" provides a summary of the available risk prediction algorithms and offers guidance on how to use them.
Individual risk assessment in secondary prevention for cardiovascular disease
Better individualised estimates of risk in patients with previous cardiovascular disease will enable more intensive treatment, motivation and follow-up in identified high-risk individuals.
The ESC Prevention of Cardiovascular Disease programme is supported by AMGEN, AstraZeneca, Ferrer for good, and Sanofi and Regeneron in the form of educational grants.
Our mission: To reduce the burden of cardiovascular disease.